Company intelligence
MENARINI Group
About MENARINI Group
The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group
Verified activity
Signals from MENARINI Group
2 published signals
Presence & Recognition
Menarini Group participated in the ERS Congress 2026 in Barcelona, focusing on the theme United for better breathing.
Reported by MENARINI Group
Products & Services
Menarini Group in-licenses an investigational GLP-1 receptor agonist for adult obesity and overweight in Europe.
Reported by MENARINI Group